Defining the cellular and molecular pathogenesis of ulcerative colitis
定义溃疡性结肠炎的细胞和分子发病机制
基本信息
- 批准号:G0802068/1
- 负责人:
- 金额:$ 149.41万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2009
- 资助国家:英国
- 起止时间:2009 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Ulcerative colitis (UC) is an incurable disease of the guts which can affect men, women and children of all ages. It can cause severe abdominal pain, bloody diarrhoea, and even cancer and many patients require surgery to help with these symptoms and complications. What is particularly worrying is that this condition is becoming more common and nobody really knows what causes it or what the best treatment is.This research aims to understand more about what causes UC and may lead to the development of new therapies.Our recent work has given us great insight in to what is likely to be going on in UC. We have found that one particular gene in cells of the immune system can upset the balance between ?good? and ?bad? bacteria in the gut and trigger inflammation in the bowel. The research showed that this gene (known as T-bet) controls the production of a key protein called TNF-alpha. Without T-bet, too much of this protein gets produced, which starts the process of inflammation in the gut. This in turn allows bacteria to cross from the gut into the body, which can aggravate the inflammation and cause ulcerative colitis. Our work is uncovering the ways in which the crucial balance between ?good? and ?bad? bacteria is maintained in the gut and what goes wrong when it is upset.UC is one type of ?autoimmune disease? that occurs when the body?s immune system makes a mistake and attacks itself. This can be triggered by the breakdown of the barrier of cells that prevents immune cells from attacking bacteria in the bowel. We?ve found that the T-bet gene is essential for maintaining the integrity of that barrier ? it?s like a peacekeeper in our guts and without it, things can get nasty.Knowing more about the events that lead to ulcerative colitis opens up several possible new ways to treat it. As well as developing drugs that affect T-bet, another approach might be to use special ?regulatory immune cells?, which have already proved effective at treating ulcerative colitis in mice.These results are very important and we hope to study these mice in a more detailed way to discover new treatments for patients with this disease, such as giving back some regulatory T cells.We aim to take these findings from the lab and turn them into new treatments to help patients as quickly as possible.
溃疡性结肠炎(UC)是一种无法治愈的肠道疾病,可影响所有年龄段的男性,女性和儿童。它可以导致严重的腹痛,出血性腹泻,甚至癌症,许多患者需要手术来帮助这些症状和并发症。特别令人担忧的是,这种情况变得越来越普遍,没有人真正知道是什么导致了它,或者最好的治疗方法是什么。这项研究旨在了解更多关于什么导致了UC,并可能导致新疗法的发展。我们最近的工作让我们对UC可能发生的事情有了很大的了解。我们已经发现,免疫系统细胞中的一种特定基因可以破坏免疫系统之间的平衡。好吗?然后呢?不好吗肠道中的细菌并引发肠道炎症。研究表明,这种基因(称为T-bet)控制着一种名为TNF-α的关键蛋白质的产生。如果没有T-bet,就会产生太多的这种蛋白质,从而启动肠道炎症过程。这反过来又允许细菌从肠道进入体内,这会加剧炎症并导致溃疡性结肠炎。我们的工作是揭示如何在关键的平衡之间?好吗?然后呢?不好吗细菌是维持在肠道和什么出错时,它是心烦意乱。UC是一种类型?自身免疫性疾病当身体?的免疫系统犯了一个错误,攻击自己。这可能是由阻止免疫细胞攻击肠道细菌的细胞屏障的破坏引发的。我们?我们?我发现T-bet基因对维持屏障的完整性至关重要?是吗?溃疡性结肠炎就像我们肠道中的一个和平卫士,如果没有它,事情会变得很糟糕。了解更多导致溃疡性结肠炎的事件,可以开辟几种可能的新方法来治疗它。调节免疫细胞?已经证明对治疗小鼠溃疡性结肠炎有效。这些结果非常重要,我们希望以更详细的方式研究这些小鼠,为患有这种疾病的患者发现新的治疗方法,例如给予一些调节性T细胞。我们的目标是从实验室获得这些发现,并将其转化为新的治疗方法,以尽快帮助患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Graham Lord其他文献
Tumour infiltrating B cells discriminate checkpoint blockade-induced responses
- DOI:
10.1016/j.ejca.2022.09.022 - 发表时间:
2022-12-01 - 期刊:
- 影响因子:
- 作者:
Sara Valpione;Luca G. Campana;John Weightman;Zena Salih;Elena Galvani;Piyushkumar A. Mundra;Francesco De Rosa;Avinash Gupta;Patricio Serra-Bellver;Paul Lorigan;Theodora Germetaki;Marek Dynowski;Stephen Kitcatt;Sudhakar Sahoo;Dave Lee;Nathalie Dhomen;Graham Lord;Richard Marais - 通讯作者:
Richard Marais
Lyoplate-based multiparameter flow cytometry for the analysis of T cell subsets in human immuno-monitoring studies
- DOI:
10.1186/1479-5876-9-s2-p18 - 发表时间:
2011-11-23 - 期刊:
- 影响因子:7.500
- 作者:
Federica Villanova;Paola Di Meglio;Susanne Heck;Margaret Inokuma;Ryan Brinkman;Esperanza Perucha;Maria Hernandez Fuentes;Graham Lord;Skip Maino;Frank O Nestle - 通讯作者:
Frank O Nestle
773 A COMMON IL2RA POLYMORPHISM ALTERS NATURAL KILLER CELL IMMUNOPHENOTYPE AND FUNCTION IN CROHN'S DISEASE, WITH IMPLICATIONS FOR IL-2 BASED THERAPY
- DOI:
10.1016/s0016-5085(23)01357-4 - 发表时间:
2023-05-01 - 期刊:
- 影响因子:
- 作者:
Jennie N. Clough;Rimma Goldberg;Luke B. Roberts;Graham Lord;Peter M. Irving - 通讯作者:
Peter M. Irving
374: IMMUNE CHECKPOINT INHIBITOR-INDUCED COLITIS IS MEDIATED BY CYTOTOXIC LYMPHOCYTES AND IS RELIANT ON THE IL23/IFNγ AXIS
- DOI:
10.1016/s0016-5085(22)60200-2 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Jonathan W. Lo;Domenico Cozzetto;Matthew Madgwick;Jillian Y. Sieh;Marton Olbei;James L. Alexander;Jesús Miguéns Blanco;Hiromi Kudo;Hajir Ibraheim;Zhigang Liu;Rocio Castro Seoane;Robert Goldin;Julian Marchesi;Tamas Korcsmaros;Graham Lord;Nick Powell - 通讯作者:
Nick Powell
Graham Lord的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Graham Lord', 18)}}的其他基金
MICA: Targeted Regulatory T Cell Therapy for Inflammatory Bowel Disease
MICA:针对炎症性肠病的靶向调节性 T 细胞疗法
- 批准号:
MR/N006445/1 - 财政年份:2016
- 资助金额:
$ 149.41万 - 项目类别:
Research Grant
T-bet as a master regulator of mucosal immunity and inflammatory bowel disease.
T-bet 作为粘膜免疫和炎症性肠病的主要调节剂。
- 批准号:
MR/M003493/1 - 财政年份:2015
- 资助金额:
$ 149.41万 - 项目类别:
Research Grant
Redistribution of Gata3 by T-bet: a novel mechanism underlying T-cell lineage balance
T-bet 重新分配 Gata3:T 细胞谱系平衡的新机制
- 批准号:
BB/L010356/1 - 财政年份:2014
- 资助金额:
$ 149.41万 - 项目类别:
Research Grant
相似国自然基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
- 批准号:82371144
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
rhTβ4增强间充质干细胞调节T细胞代谢重塑治疗干眼的机制研究
- 批准号:32000530
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
胰岛素和细菌信号协同调节巨噬细胞免疫反应的作用
- 批准号:92057105
- 批准年份:2020
- 资助金额:89.0 万元
- 项目类别:重大研究计划
聚谷氨酰胺(PolyQ)疾病致病蛋白构象多态性的研究及应用
- 批准号:31970748
- 批准年份:2019
- 资助金额:60.0 万元
- 项目类别:面上项目
MAPK11通过RNA结合蛋白ELAVL1调控HTT水平的机制与病理意义研究
- 批准号:31970747
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
细胞代谢重组过程中蛋白质组热稳定性分析
- 批准号:31970706
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
Atg4B可逆氧化修饰的作用机制及其对自噬的调节研究
- 批准号:31970699
- 批准年份:2019
- 资助金额:50.0 万元
- 项目类别:面上项目
用识别EBV相关淋巴瘤抗原多肽的T细胞受体做转基因免疫治疗
- 批准号:81041002
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:专项基金项目
半群代数和半群表示
- 批准号:10961014
- 批准年份:2009
- 资助金额:18.0 万元
- 项目类别:地区科学基金项目
Cellular & Molecular Immunology
- 批准号:30824806
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:专项基金项目
相似海外基金
Defining single-channel paracellular (tight junction) conductances using nanotechnology
使用纳米技术定义单通道旁细胞(紧密连接)电导
- 批准号:
10593421 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining the mechanisms by which mutations in DNAJC7 increase susceptibility to ALS/FTD
确定 DNAJC7 突变增加 ALS/FTD 易感性的机制
- 批准号:
10679697 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining HIV Env protein expression in latently infected cells
定义潜伏感染细胞中的 HIV 包膜蛋白表达
- 批准号:
10762524 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining architecture of EC coupling machinery in situ
现场定义 EC 耦合机械的架构
- 批准号:
10711223 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining age-associated alterations in oral squamous cell carcinoma
定义口腔鳞状细胞癌与年龄相关的改变
- 批准号:
10607387 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining the MAST4 interactome in brain development and epilepsy
定义大脑发育和癫痫中的 MAST4 相互作用组
- 批准号:
10664122 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining mechanisms of mitotic spindle organization in Naegleria
耐格里虫有丝分裂纺锤体组织的定义机制
- 批准号:
10537005 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining The Role of Failed-Repair Proximal Tubule Cells in AdvancedRenal Disease in African Americans
确定修复失败的近端小管细胞在非裔美国人晚期肾病中的作用
- 批准号:
10740665 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining the functional role of CD56 on human natural killer cells
定义 CD56 对人类自然杀伤细胞的功能作用
- 批准号:
10735537 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别:
Defining key differences in mouse fibroblasts during digit regeneration and fibrosis
定义小鼠成纤维细胞在手指再生和纤维化过程中的关键差异
- 批准号:
10602674 - 财政年份:2023
- 资助金额:
$ 149.41万 - 项目类别: